A detailed history of Cresset Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 10,148 shares of BIIB stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,148
Previous 9,198 10.33%
Holding current value
$1.76 Million
Previous $1.98 Million 18.61%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $180,994 - $224,884
950 Added 10.33%
10,148 $2.35 Million
Q1 2024

May 15, 2024

SELL
$212.02 - $267.71 $247,639 - $312,685
-1,168 Reduced 11.27%
9,198 $1.98 Million
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $956,691 - $1.15 Million
4,298 Added 70.83%
10,366 $2.68 Million
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $173,003 - $195,262
-683 Reduced 10.12%
6,068 $1.56 Million
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $1.49 Million - $1.72 Million
5,401 Added 400.07%
6,751 $1.92 Million
Q1 2023

May 12, 2023

SELL
$256.56 - $292.34 $315,825 - $359,870
-1,231 Reduced 47.69%
1,350 $375,000
Q4 2022

Feb 14, 2023

SELL
$252.44 - $306.72 $80,275 - $97,536
-318 Reduced 10.97%
2,581 $714,000
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $12,460 - $17,181
-64 Reduced 2.16%
2,899 $775,000
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $113,836 - $135,373
-607 Reduced 17.0%
2,963 $602,000
Q1 2022

May 16, 2022

SELL
$193.77 - $244.14 $156,566 - $197,265
-808 Reduced 18.46%
3,570 $752,000
Q4 2021

Feb 10, 2022

SELL
$223.92 - $287.77 $75,908 - $97,554
-339 Reduced 7.19%
4,378 $1.05 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $372,414 - $485,669
1,316 Added 38.69%
4,717 $1.34 Million
Q2 2021

Aug 10, 2021

SELL
$259.0 - $414.71 $99,197 - $158,833
-383 Reduced 10.12%
3,401 $1.18 Million
Q1 2021

May 12, 2021

BUY
$242.95 - $284.63 $94,750 - $111,005
390 Added 11.49%
3,784 $1.06 Million
Q4 2020

Feb 11, 2021

SELL
$236.26 - $355.63 $218,776 - $329,313
-926 Reduced 21.44%
3,394 $831,000
Q3 2020

Nov 13, 2020

BUY
$264.77 - $305.71 $101,936 - $117,698
385 Added 9.78%
4,320 $1.23 Million
Q2 2020

Aug 04, 2020

BUY
$258.66 - $342.55 $449,809 - $595,694
1,739 Added 79.19%
3,935 $1.05 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $197,873 - $251,005
736 Added 50.41%
2,196 $695,000
Q4 2019

Feb 10, 2020

BUY
$220.06 - $304.07 $35,649 - $49,259
162 Added 12.48%
1,460 $433,000
Q3 2019

Nov 13, 2019

BUY
$217.44 - $243.88 $282,237 - $316,556
1,298 New
1,298 $302,000
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $213,588 - $235,435
-974 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $88,634 - $138,634
409 Added 72.39%
974 $230,000
Q4 2018

May 21, 2019

BUY
$278.5 - $352.75 $157,352 - $199,303
565 New
565 $170,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.